Revenue from Contracts with Customers (Tables)

12 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Revenues by Type of Service

The Company provides diagnostic test products, laboratory services to hospitals, clinical laboratories and other healthcare provider customers, and enters into collaboration agreements with government agencies and healthcare providers. The revenues by type of service consist of the following:

	Years Ended December,
	2021		2020
Product sales	$	2,656,669	$	2,704,364
Laboratory services		813,210		167,736
Collaboration revenue		836,152		1,342,341
Total revenue	$	4,306,031	$	4,214,441

Schedule of Revenues by Geography

Revenues by geography are as follows:

	Years Ended December,
	2021		2020
Domestic	$	1,203,748	$	1,917,367
International		3,102,283		2,297,074
Total revenue	$	4,306,031	$	4,214,441

Summary of Changes in Deferred Revenue

Deferred revenue

Changes in deferred revenue for the period were as follows:

Balance at December 31, 2019	$	9,808
Acquired deferrals from Curetis		829,275
Revenue recognized in the period from amounts acquired from Curetis		(870,114	)
Effect of foreign exchange rates		40,839
Balance at December 31, 2020		9,808
New deferrals, net of amounts recognized in the current period		—
Amounts returned to customers		(9,808	)
Effect of foreign exchange rates		—
Balance at December 31, 2021	$	—